A PHASE III, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER STUDY TO EVALUATE THE EFFICACY, SAFETY, PHARMACOKINETICS, AND PHARMACODYNAMICS OF SATRALIZUMAB AS MONOTHERAPY OR IN ADDITION TO BASELINE THERAPY IN PATIENTS WITH MYELIN OLIGODENDROCYTE GLYCOPROTEIN ANTIBODY-ASSOCIATED DISEASE (MOGAD)
![](https://researchstudies.cuanschutz.edu/Content/images/study-category-images/brain-nervous.jpg)
Details
Age
Adult
Locations
Brain Imaging Center (BIC)
Outpatient CTRC
University of Colorado Hospital
Principal Investigator
![Photograph of Jeffrey Bennett](https://som.ucdenver.edu/FIMS/Content/faculty/3730/CU-Doctors-3730.jpg)
Jeffrey Bennett
Study ID
Protocol Number: 23-0648
Categories
Is this Study for You?
Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers